CCL2 and glomerulosclerosis: Poly pretreatment in UUO mice mitigated glomerulosclerosis and tubulointerstitial fibrosis, reducing key factors (FN, VEGF, MCP-1, Rantes), showcasing FLL’s potential in kidney fibrosis protection [104].